$8m to grow Estech's cardiac surgery sales
This article was originally published in Clinica
Executive Summary
Privately-held cardiac surgery device manufacturer Endoscopic Technologies, or Estech, has completed an $8m equity financing round led by NBGI Ventures. The funds will be used to further expand commercialisation of the Estech's products, which are used by the cardiothoracic surgeon to perform minimally-invasive valve repair and replacement, coronary bypass and radiofrequency-based cardiac ablation procedures. This recent funding, to which Estech's existing shareholders also contributed, is in addition to the $11.3m which the San Ramon, California-based company raised in September 2008.